Quoin Pharmaceuticals, Ltd. (QNRX) Stock Ticker
Market factors today
Unlock the full QNRX picture
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.
QNRX stock facts
| Ticker symbol | QNRX |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $12.9M |
| CEO | Michael Myers |
| Employees | 4 |
| Headquarters | Ashburn, VA, US |
| IPO date | 2016-08-01 |
| Website | quoinpharma.com |
What you can see for QNRX on Tickr
Live QNRX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the QNRX report.
Rankings
FAQ
What is the ticker symbol for Quoin Pharmaceuticals, Ltd.?
The ticker symbol for Quoin Pharmaceuticals, Ltd. is QNRX, listed on the NASDAQ Capital Market.
What is QNRX?
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside…